Variation Biotechnologies Inc.

$55,976,000.00 CAD

≈ $1.34 for every person in Canada ≈ 715 Canadians' average pay for a year

Department: Innovation, Science and Economic Development Canada
Program: SIF Stream2- Growth
Recipient country: Canada
Fiscal year: 2020-2021
Agreement period: April 13, 2020 – March 31, 2035
Reference: ic:033-2020-2021-Q2-815774

Published purpose

This project will support the development of Canada’s medical countermeasures (MCMs) in immediate response to COVID-19. Variation Biotechnologies Inc. (VBI) will advance the development of an enveloped Virus-Like-Particle (eVLP) vaccine candidate through clinical trials to provide protection against SARS-COV2 (COVID-19), MERS and SARS.

In plain English AI-generated

This project supports the development of COVID-19, MERS, and SARS vaccine candidates by advancing a virus-like-particle vaccine through clinical trials in Canada.

Category: Health Primarily funds activity in Canada

Based on the published description. See how AI categorization works — the linked official record is authoritative.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful

View official source record Imported October 12, 2026 from open.canada.ca Grants & Contributions